Literature DB >> 19562043

A Review of Challenges in the Use of fMRI for Disease Classification / Characterization and A Projection Pursuit Application from Multi-site fMRI Schizophrenia Study.

Oguz Demirci1, Vincent P Clark, Vincent A Magnotta, Nancy C Andreasen, John Lauriello, Kent A Kiehl, Godfrey D Pearlson, Vince D Calhoun.   

Abstract

Functional magnetic resonance imaging (fMRI) is a fairly new technique that has the potential to characterize and classify brain disorders such as schizophrenia. It has the possibility of playing a crucial role in designing objective prognostic/diagnostic tools, but also presents numerous challenges to analysis and interpretation. Classification provides results for individual subjects, rather than results related to group differences. This is a more complicated endeavor that must be approached more carefully and efficient methods should be developed to draw generalized and valid conclusions out of high dimensional data with a limited number of subjects, especially for heterogeneous disorders whose pathophysiology is unknown. Numerous research efforts have been reported in the field using fMRI activation of schizophrenia patients and healthy controls. However, the results are usually not generalizable to larger data sets and require careful definition of the techniques used both in designing algorithms and reporting prediction accuracies. In this review paper, we survey a number of previous reports and also identify possible biases (cross-validation, class size, e.g.) in class comparison/prediction problems. Some suggestions to improve the effectiveness of the presentation of the prediction accuracy results are provided. We also present our own results using a projection pursuit algorithm followed by an application of independent component analysis proposed in an earlier study. We classify schizophrenia versus healthy controls using fMRI data of 155 subjects from two sites obtained during three different tasks. The results are compared in order to investigate the effectiveness of each task and differences between patients with schizophrenia and healthy controls were investigated.

Entities:  

Year:  2008        PMID: 19562043      PMCID: PMC2701746          DOI: 10.1007/s11682-008-9028-1

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  31 in total

Review 1.  Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification.

Authors:  Richard Simon; Michael D Radmacher; Kevin Dobbin; Lisa M McShane
Journal:  J Natl Cancer Inst       Date:  2003-01-01       Impact factor: 13.506

2.  Brain magnetic resonance imaging with contrast dependent on blood oxygenation.

Authors:  S Ogawa; T M Lee; A R Kay; D W Tank
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 3.  When is a genomic classifier ready for prime time?

Authors:  Richard Simon
Journal:  Nat Clin Pract Oncol       Date:  2004-11

4.  Reducing interscanner variability of activation in a multicenter fMRI study: controlling for signal-to-fluctuation-noise-ratio (SFNR) differences.

Authors:  Lee Friedman; Gary H Glover
Journal:  Neuroimage       Date:  2006-09-06       Impact factor: 6.556

5.  Classification of adolescent psychotic disorders using linear discriminant analysis.

Authors:  Patricia J Pardo; Apostolos P Georgopoulos; John T Kenny; Traci A Stuve; Robert L Findling; S Charles Schulz
Journal:  Schizophr Res       Date:  2006-06-23       Impact factor: 4.939

Review 6.  Classification based upon gene expression data: bias and precision of error rates.

Authors:  Ian A Wood; Peter M Visscher; Kerrie L Mengersen
Journal:  Bioinformatics       Date:  2007-03-28       Impact factor: 6.937

Review 7.  Working memory.

Authors:  A Baddeley
Journal:  Science       Date:  1992-01-31       Impact factor: 47.728

8.  Applying spatial distribution analysis techniques to classification of 3D medical images.

Authors:  Dragoljub Pokrajac; Vasileios Megalooikonomou; Aleksandar Lazarevic; Despina Kontos; Zoran Obradovic
Journal:  Artif Intell Med       Date:  2005-03       Impact factor: 5.326

9.  Multivariate examination of brain abnormality using both structural and functional MRI.

Authors:  Yong Fan; Hengyi Rao; Hallam Hurt; Joan Giannetta; Marc Korczykowski; David Shera; Brian B Avants; James C Gee; Jiongjiong Wang; Dinggang Shen
Journal:  Neuroimage       Date:  2007-04-19       Impact factor: 6.556

10.  Grey matter changes can improve the prediction of schizophrenia in subjects at high risk.

Authors:  Dominic E Job; Heather C Whalley; Andrew M McIntosh; David G C Owens; Eve C Johnstone; Stephen M Lawrie
Journal:  BMC Med       Date:  2006-12-07       Impact factor: 8.775

View more
  39 in total

1.  Automated classification of fMRI during cognitive control identifies more severely disorganized subjects with schizophrenia.

Authors:  Jong H Yoon; Danh V Nguyen; Lindsey M McVay; Paul Deramo; Michael J Minzenberg; J Daniel Ragland; Tara Niendham; Marjorie Solomon; Cameron S Carter
Journal:  Schizophr Res       Date:  2012-01-25       Impact factor: 4.939

Review 2.  Function biomedical informatics research network recommendations for prospective multicenter functional MRI studies.

Authors:  Gary H Glover; Bryon A Mueller; Jessica A Turner; Theo G M van Erp; Thomas T Liu; Douglas N Greve; James T Voyvodic; Jerod Rasmussen; Gregory G Brown; David B Keator; Vince D Calhoun; Hyo Jong Lee; Judith M Ford; Daniel H Mathalon; Michele Diaz; Daniel S O'Leary; Syam Gadde; Adrian Preda; Kelvin O Lim; Cynthia G Wible; Hal S Stern; Aysenil Belger; Gregory McCarthy; Burak Ozyurt; Steven G Potkin
Journal:  J Magn Reson Imaging       Date:  2012-02-07       Impact factor: 4.813

3.  Diffusion tensor imaging reliably differentiates patients with schizophrenia from healthy volunteers.

Authors:  Babak A Ardekani; Ali Tabesh; Serge Sevy; Delbert G Robinson; Robert M Bilder; Philip R Szeszko
Journal:  Hum Brain Mapp       Date:  2011-01       Impact factor: 5.038

Review 4.  Neuroimaging in Psychiatry and Neurodevelopment: why the emperor has no clothes.

Authors:  Ashley N Anderson; Jace B King; Jeffrey S Anderson
Journal:  Br J Radiol       Date:  2019-03-15       Impact factor: 3.039

5.  Common component classification: what can we learn from machine learning?

Authors:  Ariana Anderson; Jennifer S Labus; Eduardo P Vianna; Emeran A Mayer; Mark S Cohen
Journal:  Neuroimage       Date:  2010-06-25       Impact factor: 6.556

6.  Supervised machine learning for diagnostic classification from large-scale neuroimaging datasets.

Authors:  Pradyumna Lanka; D Rangaprakash; Michael N Dretsch; Jeffrey S Katz; Thomas S Denney; Gopikrishna Deshpande
Journal:  Brain Imaging Behav       Date:  2020-12       Impact factor: 3.978

Review 7.  Noise concerns and post-processing procedures in cerebral blood flow (CBF) and cerebral blood volume (CBV) functional magnetic resonance imaging.

Authors:  Manus J Donahue; Meher R Juttukonda; Jennifer M Watchmaker
Journal:  Neuroimage       Date:  2016-09-11       Impact factor: 6.556

8.  Mining the mind research network: a novel framework for exploring large scale, heterogeneous translational neuroscience research data sources.

Authors:  Henry J Bockholt; Mark Scully; William Courtney; Srinivas Rachakonda; Adam Scott; Arvind Caprihan; Jill Fries; Ravi Kalyanam; Judith M Segall; Raul de la Garza; Susan Lane; Vince D Calhoun
Journal:  Front Neuroinform       Date:  2010-04-21       Impact factor: 4.081

9.  Classification of spatially unaligned fMRI scans.

Authors:  Ariana Anderson; Ivo D Dinov; Jonathan E Sherin; Javier Quintana; A L Yuille; Mark S Cohen
Journal:  Neuroimage       Date:  2009-08-24       Impact factor: 6.556

10.  Neuroimaging predictors of cognitive performance across a standardized neurocognitive battery.

Authors:  David R Roalf; Kosha Ruparel; Raquel E Gur; Warren Bilker; Raphael Gerraty; Mark A Elliott; R Sean Gallagher; Laura Almasy; Michael F Pogue-Geile; Konasale Prasad; Joel Wood; Vishwajit L Nimgaonkar; Ruben C Gur
Journal:  Neuropsychology       Date:  2013-12-23       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.